Search   |     Toll free: +1-800-447-9407   |

Human Factors/ Usability Studies following ISO62366, the FDA Guidance, and the new FDA Draft Guidance

Instructor Edwin Waldbusser
Webinar ID 36725
Duration 60 Minutes  

Webinar Price Details


Human Factors/ Usability is the analysis of how people interact with medical devices. The process of conducting rigorous human factors studies throughout the design process, integrating it with the device risk analysis and design process, and validating the effectiveness of the studies will be explained. 

The various types and methods of human factors analysis will be explained. This process conforms to the new ISO 62366 standard and the new FDA Guidance document.

Why should you Attend

The FDA will only approve devices that are designed so that it is practically impossible for people to accidentally harm themselves even if they use the device improperly. The FDA has replaced the term "user error" with "use error". This means that user error is considered by the FDA to be a device nonconformity because human factors should be considered in the design process. The burden is on the device designer to create an "idiot-proof" product.

Handouts the use of specification templates, user interface evaluation templates, and usability validation control forms.

Areas Covered in the Session

  • User error versus use error
  • Use related Hazards and Risk Analysis
  • User Profiles
  • Use Scenarios
  • Step-by-step Human Factors Program Development
  • Validation

Who Will Benefit

  • Engineer
  • Engineer Management
  • Quality Assurance
  • Regulatory

Speaker Profile

Edwin Waldbusser is a consultant retired from industry after 20 years in management of development of medical devices (5 patents). He has been consulting in the US and internationally in the areas of design control, risk analysis and software validation for the past 8 years. Mr. Waldbusser has a BS in Mechanical Engineering and an MBA. He is a Lloyds of London certified ISO 9000 Lead Auditor and a member of the Thomson Reuters Expert Witness network.